We also analyzed the TCGA RNA-seq data from 238 VHL-deficient ccRCC patients and found that samples with higher ZMYND8 mRNA levels expressed higher levels of PRC2 target genes HOXA3, RUNX2, and TCF7 (Fig. 3E). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.